Debate over compounding bill centers on supplier verification, patient safety and access HB 2,613 would require tighter quality-assurance measures for compounded drugs; drugmakers and patient‑safety groups urged safeguards targeting high‑volume, mass‑marketed compounded GLP‑1 products, while pharmacists, hospitals and community clinics warned the bill as written would overreach, raise costs, delay care and risk limiting essential patient‑specific compounding.

A fierce debate is brewing over House Bill 2,613, as lawmakers clash with healthcare providers on how to balance patient safety and access to essential compounded medications.

Get the details!

#WA #PatientSafety #CitizenPortal #PharmaceuticalRegulation #QualityAssurance

Pennsylvania bill allows healthcare practice name on prescription labels for certain pharmaceuticals Legislation permits prescribers to use practice name on mifepristone and misoprostol labels

Pennsylvania just made a significant shift in healthcare by allowing prescribers to include their practice name on labels for mifepristone and misoprostol.

Click to read more!

#PA #CitizenPortal #PharmaceuticalRegulation #HealthcareAccess #PennsylvaniaHealthcare

Minnesota sets new requirements for prescription drugs of substantial public interest Commissioner will post quarterly lists of influential prescription drugs starting January 2024

Minnesota's new Senate Bill 2477 aims to shine a light on prescription drug pricing by requiring quarterly lists of high-impact medications—could this be the change consumers have been waiting for?

Click to read more!

#MN #CitizenPortal #ConsumerAccountability #PharmaceuticalRegulation

Oklahoma sets stricter penalties for PBM violations under new legislation Oklahoma fines PBMs $10,000 daily for noncompliance and may suspend licenses after six months.

Oklahoma is cracking down on Pharmacy Benefit Managers with a bold new bill that could fine them $10,000 a day for violations—will this reshape the future of prescription drug access?

Click to read more!

#OK #ConsumerProtection #PharmaceuticalRegulation #CitizenPortal #HealthcareAccess

Maryland Legislature debates prescription drug affordability bill amid heated arguments Maryland lawmakers discuss new bill aimed at reducing prescription drug costs for residents.

Maryland lawmakers are locked in a fierce battle over a bill that could dramatically lower insulin costs, revealing deep divisions on healthcare affordability.

Read the full story

#MD #PharmaceuticalRegulation #MarylandHealthcare #PrescriptionDrugCosts #HealthcareAffordability #CitizenPortal

Legislative Assembly mandates data sharing conditions for drug claims Assembly requires data submission for drug claims unless exempted by federal law

House Bill 1473 could revolutionize how North Dakotans access their medications by cutting through red tape and ensuring timely care for patients.

Click to read more!

#ND #PatientCare #NorthDakotaPharmaceuticals #PharmaceuticalRegulation #CitizenPortal #HealthcareAccess